Филтриране по Last updated date SelectСледПредиFrom - To Дата Крайна дата This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Резултати (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank EMA website briefly unavailable on 15 March 2021 11 March 2021NewsCorporate EMA starts rolling review of Eli Lilly antibodies bamlanivimab and etesevimab for COVID-19 11 March 2021NewsHumanCOVID-19Medicines COVID-19 Vaccine AstraZeneca: PRAC preliminary view suggests no specific issue with batch used in Austria 10 March 2021NewsHumanCOVID-19Vaccines EMA issues advice on use of antibody combination (bamlanivimab / etesevimab) 5 March 2021NewsHumanCOVID-19Medicines EMA website briefly unavailable on 8 March 2021 5 March 2021NewsCorporate EMA starts rolling review of the Sputnik V COVID-19 vaccine 4 March 2021NewsHumanCOVID-19Vaccines EMA review of regdanvimab for COVID-19 to support national decisions on early use 2 March 2021NewsHumanCOVID-19Medicines EMA and Health Canada publish clinical data used to support their authorisations of the Moderna COVID-19 vaccine 2 March 2021NewsHumanCOVID-19Vaccines EMA issues advice on use of REGN-COV2 antibody combination (casirivimab / imdevimab) 26 February 2021NewsHumanCOVID-19Medicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 February 2021 26 February 2021NewsHumanCOVID-19BiosimilarsGeneric and hybrid medicinesMedicinesReferrals 1 … 66 67 68 69 70 Page 70 of 380 71 72 73 74 … 380
EMA starts rolling review of Eli Lilly antibodies bamlanivimab and etesevimab for COVID-19 11 March 2021NewsHumanCOVID-19Medicines
COVID-19 Vaccine AstraZeneca: PRAC preliminary view suggests no specific issue with batch used in Austria 10 March 2021NewsHumanCOVID-19Vaccines
EMA issues advice on use of antibody combination (bamlanivimab / etesevimab) 5 March 2021NewsHumanCOVID-19Medicines
EMA review of regdanvimab for COVID-19 to support national decisions on early use 2 March 2021NewsHumanCOVID-19Medicines
EMA and Health Canada publish clinical data used to support their authorisations of the Moderna COVID-19 vaccine 2 March 2021NewsHumanCOVID-19Vaccines
EMA issues advice on use of REGN-COV2 antibody combination (casirivimab / imdevimab) 26 February 2021NewsHumanCOVID-19Medicines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 February 2021 26 February 2021NewsHumanCOVID-19BiosimilarsGeneric and hybrid medicinesMedicinesReferrals